Publications (17) Publications in which a researcher has participated

filter_list Hepatology

2025

  1. Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention

    Journal of Endocrinological Investigation, Vol. 48, Núm. 4, pp. 987-1003

  2. DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy

    Journal of Viral Hepatitis, Vol. 32, Núm. 2

  3. Liver transplantation for primary and secondary liver tumors: Patient-level meta-analyses compared to UNOS conventional indications

    Hepatology, Vol. 81, Núm. 6, pp. 1700-1713

  4. Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma

    Journal of experimental & clinical cancer research : CR, Vol. 44, Núm. 1, pp. 13

2024

  1. Anatomic Versus Non-anatomic Liver Resection for Intrahepatic Cholangiocarcinoma: A Systematic Review and Patient-Level Meta-Analysis

    Annals of Surgical Oncology, Vol. 31, Núm. 13, pp. 9170-9182

  2. Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma

    Biomolecules, Vol. 14, Núm. 6

  3. Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment

    Journal of Physiology and Biochemistry

  4. Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients

    Annals of surgical oncology, Vol. 31, Núm. 9, pp. 5615-5630

  5. First consensus document of waiting list prioritization for liver transplantation by the Spanish Society of Liver Transplantation (SETH)

    Revista espanola de enfermedades digestivas

  6. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

    Annals of Oncology, Vol. 35, Núm. 5, pp. 448-457

  7. Impact of Liver Cirrhosis, Severity of Cirrhosis, and Portal Hypertension on the Difficulty and Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies

    Annals of Surgical Oncology, Vol. 31, Núm. 1, pp. 97-114

  8. Liver transplantation in colorectal metastases. Is there an indication for this procedure?

    Revista espanola de enfermedades digestivas, Vol. 116, Núm. 2, pp. 59-62

  9. Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy

    Journal of Vascular and Interventional Radiology, Vol. 35, Núm. 9, pp. 1253-1267.e1

  10. Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)

    Surgical Oncology, Vol. 52

  11. Sex-Dependent Gut Microbiota Features and Functional Signatures in Metabolic Disfunction-Associated Steatotic Liver Disease

    Nutrients , Vol. 16, Núm. 23

  12. Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial

    United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1016-1027

  13. The Impact of Portal Hypertension Assessment Method on the Outcomes of Hepatocellular Carcinoma Resection: A Meta-Analysis of Matched Cohort and Prospective Studies

    Annals of Surgery, Vol. 280, Núm. 1, pp. 46-55